MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
106 hedge funds and large institutions have $485M invested in Marinus Pharmaceuticals, Inc in 2023 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
Holders
106
Holding in Top 10
3
Calls
$11.1M
Puts
$1.99M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$20.3M | |
| 3 | +$8.12M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.57M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$6.65M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$9.96M | |
| 3 | -$9.22M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$8.66M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$8.4M |